Use of agent for induction of specific immunity against severe acute respiratory syndrome sars-cov-2 for population revaccination in people over 60 and/or with chronic diseases (versions)

The invention relates to the field of biotechnology, immunology and virology. The use of the agent is disclosed, said agent containing a component 1, which is an agent in the form of expression vector based on genome of recombinant strain of human adenovirus serotype 26 with E1 and E3 sites deleted...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: OZHAROVSKAIA Tatiana Andreevna, Tokarskaia Elizaveta Aleksandrovna, Kriukov Evgenii Vladimirovich, Kutaev Dmitrii Anatolevich, ZUBKOVA Olga Vadimovna, Chernetsov Vladimir Aleksandrovich, Erokhova Alina Sergeevna, DOLZHIKOVA Inna Vadimovna, IZHAEVA Fatima Magomedovna, POPOVA Olga, SHCHERBININ Dmitrii Nikolaevich, BOTIKOV Andrei Gennadevich, SHCHEBLIAKOV Dmitrii Viktorovich, Nikitenko Natalia Anatolevna, Babira Vladimir Fedorovich, TUKHVATULIN Amir Ildarovich, ESMAGAMBETOV Ilias Bulatovich, SEMIKHIN Aleksandr Sergeevich, Dzharullaeva Alina Shakhmirovna, GINTSBURG Aleksandr Leonidovich, Loginova Svetlana Iurevna, Naroditskii Boris Savelevich, TUKHVATULINA Natalia Mikhailovna, LUBENETS Nadezhda Leonidovna, Logunov Denis Iurevich, GROUSOVA Daria Mikhailovna
Format: Patent
Sprache:eng ; heb
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!